• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Results of a Dutch Phase II trial with the LHRH agonist buserelin in patients with metastatic prostatic cancer.

作者信息

Debruyne F M, Karthaus H F, Schröder F H, de Voogt H J, de Jong F H, Klijn J G

出版信息

Prog Clin Biol Res. 1985;185A:251-70.

PMID:3929265
Abstract
摘要

相似文献

1
Results of a Dutch Phase II trial with the LHRH agonist buserelin in patients with metastatic prostatic cancer.
Prog Clin Biol Res. 1985;185A:251-70.
2
[Treatment of advanced cancer of the prostate with an analog of LHRH, buserelin].用促黄体生成素释放激素类似物布舍瑞林治疗晚期前列腺癌
Ann Urol (Paris). 1986;20(2):95-7.
3
[Treatment of prostatic cancer with slow-release formulation of luteinizing hormone releasing hormone (LH-RH) analog].
Hinyokika Kiyo. 1988 Mar;34(3):555-60.
4
[Treatment with D-Trp-6-LHRH. Plasma levels and gonadotropic response].
Pathol Biol (Paris). 1984 Oct;32(8):906-8.
5
Individual variation of hormonal recovery after cessation of luteinizing hormone-releasing hormone agonist therapy in men receiving long-term medical castration therapy for prostate cancer.接受前列腺癌长期药物去势治疗的男性在促黄体生成素释放激素激动剂治疗停止后激素恢复的个体差异。
Scand J Urol Nephrol. 2006;40(3):198-203. doi: 10.1080/00365590600641533.
6
[Clinical experience with single and multiple subcutaneous administration of LHRH analog Buserelin (Hoe 766) in prostatic carcinoma: endocrinological study of optimum subcutaneous doses].[促黄体生成素释放激素类似物布舍瑞林（Hoe 766）单次及多次皮下注射治疗前列腺癌的临床经验：最佳皮下剂量的内分泌学研究]
Hinyokika Kiyo. 1988 Jul;34(7):1297-307.
7
Treatment with gonadotrophin releasing hormone analogue in advanced prostatic cancer.促性腺激素释放激素类似物治疗晚期前列腺癌。
Br Med J (Clin Res Ed). 1983 Apr 23;286(6374):1309-12. doi: 10.1136/bmj.286.6374.1309.
8
Metastatic prostate cancer under long term pernasal buserelin or intramuscular decapeptyl depot treatment.
Prog Clin Biol Res. 1987;243A:207-20.
9
Kinetic evaluation of the effect of LHRH analog on prostatic cancer using transrectal ultrasonotomography.
Prostate. 1987;10(1):11-7. doi: 10.1002/pros.2990100104.
10
[Clinical effect of slow release (depot) formulation of the LH-RH analogue ICI 118630 (Zoladex) in patients with prostatic carcinoma].[促黄体生成素释放激素类似物ICI 118630（诺雷德）缓释（长效）制剂对前列腺癌患者的临床疗效]
Hinyokika Kiyo. 1987 Jan;33(1):141-50.

引用本文的文献

1
Pharmacokinetics and endocrine effects of the LHR analogue buserelin after subcutaneous implantation of a slow release preparation in prostatic cancer patients.在前列腺癌患者皮下植入缓释制剂后，促黄体生成激素释放激素（LHR）类似物布舍瑞林的药代动力学和内分泌效应。
Urol Res. 1989;17(1):43-6. doi: 10.1007/BF00261050.
2
Buserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical profile.布舍瑞林。对其药效学和药代动力学特性以及临床概况的综述。
Drugs. 1990 Mar;39(3):399-437. doi: 10.2165/00003495-199039030-00007.